Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference23 articles.
1. Pathology of lung cancer.;Travis;Clin Chest Med,2011
2. Comprehensive genomic characterization of squamous cell lung cancers.;Nature,2012
3. Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology.;Ettinger;J Natl Compr Canc Netw,2017
4. New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib.;Hirsh;Onco Targets Ther,2017
5. High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma.;Lee;Clin Cancer Res,2012
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunostaining and gene expression of epidermal growth factor receptors (HER1/HER2) in canine cutaneous squamous cell carcinoma;Research in Veterinary Science;2024-09
2. Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives;Cancer Biology & Medicine;2022-12-05
3. An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations;Cancer Research Communications;2022-01-07
4. A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient;ERJ Open Research;2021-01
5. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Patients with Non-small Cell Lung Cancer of Squamous Histology: Focus on Afatinib;Oncology & Haematology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3